Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Curr Pharm Des. 2018;24(37):4436-4444. doi: 10.2174/1381612825666181219162655.
Cardiovascular disease (CVD) is the first leading cause of morbidity and mortality in developing and developed countries. Circulating exosomes have recently been identified as extracellular transporters, detectable in biological fluids. Exosomes have established a new era in diagnosing diseases, especially CVD. Determination of exosome profiles, e.g., miRNAs, for different health states such as myocardial injury still requires further studies. In this review, we will discuss the role of exosomes as a potential biomarker in CVD, with particular emphasis on recent advances in the methods to study exosomes, isolation, detection, and characterization.
心血管疾病(CVD)是发展中国家和发达国家发病率和死亡率的首要原因。循环外泌体最近被确定为可在生物体液中检测到的细胞外转运体。外泌体开创了诊断疾病的新时代,尤其是 CVD。确定不同健康状态(如心肌损伤)中外泌体谱(例如 miRNA)仍需要进一步研究。在这篇综述中,我们将讨论外泌体作为 CVD 潜在生物标志物的作用,特别强调研究外泌体的方法、分离、检测和特征方面的最新进展。